Genflow Biosciences (GENF) Engages ON365 Partners as Investor Relations Adviser to Expand Reach of SIRT6 Gene Therapy Platform

Genflow Biosciences (GENF) Engages ON365 Partners as Investor Relations Adviser to Expand Reach of SIRT6 Gene Therapy Platform →

Genflow Biosciences Plc (LSE: GENF | OTCQB: GENFF), a UK-based biotechnology firm specializing in gene therapies targeting age-related diseases, has appointed ON365 Partners Inc. as its new investor relations adviser effective immediately.…